Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome

1995 ◽  
Vol 74 (1) ◽  
pp. 56-60 ◽  
Author(s):  
Leopoldo Falsetti ◽  
Edda Pasinetti
Keyword(s):  
Lipid Metabolism ◽  
Oral Contraceptive ◽  
Polycystic Ovary Syndrome ◽  
Cyproterone Acetate ◽  
Polycystic Ovary ◽  
Ovary Syndrome ◽  
Term Administration

Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate

2011 ◽  
Vol 27 (12) ◽  
pp. 971-977 ◽  
Author(s):  
George Markantes ◽  
Alexandros D. Saltamavros ◽  
Vasiliki Vervita ◽  
Anastasia K. Armeni ◽  
Anastasia Karela ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Polycystic Ovary Syndrome ◽  
Young Women ◽  
Cyproterone Acetate ◽  
Ethinyl Estradiol ◽  
Polycystic Ovary ◽  
Plasma Viscosity ◽  
Ovary Syndrome

The influence of long-term administration of conjugated estrogens and antiandrogens to serum leptin levels in women with polycystic ovary syndrome

2000 ◽  
Vol 14 (3) ◽  
pp. 169-172 ◽  
Author(s):  
D. K. Panidis ◽  
D. H. Rousso ◽  
I. M. Matalliotakis ◽  
A. I. Kourtis ◽  
P. Stamatopoulos ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Ovary Syndrome ◽  
Serum Leptin ◽  
Conjugated Estrogens ◽  
Term Administration

The metabolic effects of metformin, cyproterone-acetate and their combination in women with polycystic ovary syndrome

2019 ◽  
Author(s):  
Ivana Bozic-Antic ◽  
Dusan Ilic ◽  
Tamara Bogavac ◽  
Snjezana Erceg ◽  
Mirjana Lacmanovic ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Cyproterone Acetate ◽  
Polycystic Ovary ◽  
Metabolic Effects ◽  
Ovary Syndrome
Sign in / Sign up

Export Citation Format

Share Document